Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis-Reference-Cited by-同舟云学术

Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis

Published:2020-02-24 Issue:16 Volume:39 Page:3276-3291
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

He Yongfeng,Mi Jiaqi,Olson Adam^ORCID,Aldahl Joseph,Hooker Erika^ORCID,Yu Eun-Jeong,Le Vien,Lee Dong-Hoon,Kim Won Kyung,Robins Diane M.,Geradts Joseph,Sun Zijie

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-020-1214-7.pdf

Reference54 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

2. DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African Americans, 2019. CA Cancer J Clin. 2019;69:211–33.

3. Culig Z. Role of the androgen receptor axis in prostate cancer. Urology. 2003;62:21–6.

4. Kyprianou N, Isaacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology. 1988;122:552–62.

5. Jenster G, van der Korput HA, van Vroonhoven C, van der Kwast TH, Trapman J, Brinkmann AO. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol. 1991;5:1396–404.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics;Steroids;2024-10

2. SWI/SNF chromatin remodelers in prostate cancer progression;Frontiers in Epigenetics and Epigenomics;2024-01-04

3. GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer;PeerJ;2022-10-25

4. The evolution and polymorphism of mono-amino acid repeats in androgen receptor and their regulatory role in health and disease;Frontiers in Medicine;2022-10-20

5. Interferon Beta (IFN-β)-Modified Bone Marrow Mesenchymal Stem Cells (BMSC) Impede Metastatic Tropism of Prostate Cancer via Modulating Transforming Growth Factor-Beta/Smads (TGF-Beta/Smads) Pathway;Journal of Biomaterials and Tissue Engineering;2022-10-01